Thomas A. Whitehill, M.D., F.A.C.S. · CV - T.A. Whitehill, M.D. 2002 - 2004 Member, Curriculum...

CURRICULUM VITAE

Thomas A. Whitehill, M.D., F.A.C.S.

November 15, 2007 OFFICE ADDRESS Chief of Surgical Services

Denver VA Medical Center, ECHCS Surgical Service, 4B117 (112)

1055 Clermont Street Denver, Colorado 80220 (ph) 303-393-2863

(fax) 303-315-8091 (email) [email protected] [email protected] EDUCATION

1975 - 1979 Pennsylvania State University B.S. Biophysics 1979 - 1983 University of Pennsylvania M.D. Medicine

POSTGRADUATE TRAINING

1983 - 1984 Department of Surgery Intern University of Colorado General Surgery

1984 - 1985 Department of Surgery Resident 1987 - 1989 University of Colorado General Surgery

1985 - 1987 Department of Vascular Surgery Research Fellow

University of Colorado Vascular Surgery

1989 - 1990 Department of Surgery Chief Resident University of Colorado General Surgery 1991 - 1992 Department of Vascular Surgery Research Fellow

University of Michigan Vascular Surgery

1992 - 1993 Department of Vascular Surgery Clinical Fellow University of Michigan Vascular Surgery

mailto:[email protected]

mailto:[email protected]

CV - T.A. Whitehill, M.D.

LICENSURE AND CERTIFICATIONS

1984 Diplomate, NBME 1987 - present Medical License, Colorado 1991 – 1995 Medical License, Michigan 1992 - 2012 American Board of Surgery General Surgery 1995 - 2015 American Board of Surgery Vascular Surgery 1990 - 1998 Provider ATLS 1990 - present Provider ACLS 1998 - present Medtronic Aneuryx Stent Graft certification 2004 - present Gore Excluder Stent Graft certification 2004 - present Cook Zenith Stent Graft certification

PROFESSIONAL / ACADEMIC APPOINTMENTS

1989 - 1990 University of Colorado Instructor of Surgery

1990 - 1991 University of Colorado Assistant Professor of Surgery

1990 - 1991 Denver VA Medical Center Staff Surgeon

1990 - 1991 Denver General Hospital Chief, Vascular Surgery Staff Trauma Surgeon

1991 - 1993 University of Michigan Lecturer in Surgery

1992 - 1993 Ann Arbor VA Medical Center Consulting Surgeon

1993 - 2000 University of Colorado Assistant Professor of Surgery

1993 - 2003 VA Medical Center Chief, Vascular Surgery Section 1993 - present Denver General Hospital Consulting Vascular Surgeon

1996 - 2003 VA Medical Center Assistant Chief of Surgery Clinical Operations Officer

1999 - present The Children's Hospital Consulting Vascular Surgeon 2000 - present University of Colorado Associate Professor of Surgery 2003 - 2006 University of Colorado Acting Chief, Vascular Surgery 2003 - present Denver VA Medical Center Chief of Surgery Denver, Colorado

2


HONORS, FELLOWSHIPS, AND AWARDS

1978 Phi Kappa Phi, Pennsylvania State University 1979 Magna cum laude, Pennsylvania State University 1983 Summa cum laude, Pennsylvania State University 1983 Summa cum laude, University of Pennsylvania 1985 John B. Gramlich Traveling Surgical Scholar 1986 Colorado Medical Society Presidential Gold Seal 1987 Eiseman Surgical Research Award, University of Colorado 1991 Resident Teaching Award, University of Colorado 1992 Jobst Vascular Research Fellowship, University of Michigan 1992 Student Teaching Award, University of Michigan 1992 Resident Teaching Award, University of Michigan 1995 Student Teaching Award, University of Colorado 1996 Special Contribution Award, Denver VA Medical Center 1998 American Geriatrics Society Mid-career Fellowship 1998 SERF Fellowship, Association for Surgical Education 1999 Young Surgeon Representative, American College of Surgeons

2005 The Ben Eiseman Faculty Teaching Excellence Award MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS

1990 - 1996 Colorado Vascular Surgery Society 1995 - present Rocky Mountain Vascular Surgical Society 1996 - present Western Vascular Society 1997 - present Association for Surgical Education 1998 - present American College of Surgeons

SERVICE: INTRAMURAL Denver General Hospital

1990 - 1991 Director, Medical Student Education 1990 - 1991 Director, Non-invasive Vascular Lab

University of Colorado School of Medicine

1990 - 1991 Member, Faculty Senate 1990 - 1991 Residency Selection Committee, Department of Surgery 1993 - present Residency Selection Committee, Department of Surgery 1997 - present Clerkship Director, Medical Student Program, Surgery

1997 - present AHEC Liaison, Medical Student Program, Surgery 1997 - 2003 Curriculum Committee 1997 - 1999 Curriculum Review Committee 1998 - 2004 Medical Student Promotions Committee 2000 - present Faculty Promotion/Tenure Committee, Department of Surgery 2002 - 2004 Member, Faculty Senate

3


2002 - 2004 Member, Curriculum Improvement Task Force 2003 - 2005 Chairman, Faculty Promotion/Tenure Committee, Dept. Surgery 2003 - 2005 Denver Health Medical Center Education Liaison Group 2004 - present Operative and Peri-operative Care Clerkship Director 2004 Member, Search Committee – Sr. Associate Dean/Education 2004 - present Member, Curriculum Oversight Committee 2004 - present Member, Evaluation Assessment and Outcomes Committee University of Colorado Hospital 1999 - 2000 Operative and Other Invasive Procedures Committee 2000 - 2006 Chairman, Operative and Other Invasive Procedures Committee 2003 - 2006 Cardiac & Vascular Center Director’s Group 2004 - 2006 Member-at-large, Medical Board

Denver VA Medical Center

1993 - 2003 Director, Non-invasive Vascular Lab 1994 - 1996 Infection Control Committee 1994 - present Director, Medical Student Education [Surgery] 1994 - 1998 Medical Records Committee 1995 - 1997 Chairman, Priority Process Committee 1995 - 1997 Performance Improvement Committee 1995 - 1999 Chairman, Critical Care Committee 1995 - 2000 Lead Physician/Surgeon, PACT Initiative 1997 - 2000 Director, Ambulatory Surgery 1998 - 2000 Operative/Invasive Procedures Review Committee 2000 - present Chairman, Operative/Invasive Procedures Review Committee 2006 Member, Search Committee – Chief of Staff 2006 – present Member, Search Committee - Chief of Medicine

SERVICE: EXTRAMURAL

1995 - present Journal of Vascular Surgery Manuscript Reviewer 1995 - present Annals of Vascular Surgery Book Reviewer 1997 - present Arthritis & Rheumatism Manuscript Reviewer 1998 - 1999 Rocky Mountain Vascular Society Councilman at Large

1999 - 2002 American College of Surgeons - CO Councilor 1999 - 2002 Rocky Mountain Vascular Society Program Coordinator 1999 - present Journal of Vascular Surgery Book Reviewer 2000 - present American College of Surgeons Committee on Applicants 2000 - present American Board of Surgery Associate Examiner 2002 - 2003 American College of Surgeons – CO Secretary/Treasurer 2002 - 2005 Rocky Mountain Vascular Society Secretary/Treasurer 2003 - 2004 American College of Surgeons – CO President Elect 2004 - present NBME Surgical Subject Exam Exam reviewer 2004 - 2005 American College of Surgeons – CO President

4


2004 – present Center for Personalized Education Consultant for Physicians (CPEP)

2006 - present Member – DSMB: A randomized single blind trial to assess the effectiveness of maintaining patency and safety of the Vascular Wrap™ paclitaxel-eluting mesh after surgical implantation with the Lifespan® graft in the upper extremity for hemodialysis vascular access.

RESEARCH FUNDING AND PROJECTS

1. Psicor Cardiovascular Corporation. $60,000. 1993-98. "The Role of the Endothelial Cell in the Passivation of Extracorporeal Circuits." Principal Investigator.

2. Sigma Tau Pharmaceuticals. $150,600. 1993-1995. “Safety and Efficacy of

Propionyl-L-Carnitine in Patients with Intermittent Claudication.” Sub-Investigator.

3. VA Cooperative Studies Center, Perry Point, MD. $1,256,000. 1993-2000.

“CSP #379 – Aneurysm Detection and Management Study (ADAM).” Co-Investigator.

4. Gensia Pharmaceuticals, Inc. $120,000. 1993-1995. “Randomized,

multicenter clinical evaluation of acadesine for prevention of cardiac complications after peripheral vascular surgery.” Co-Investigator.

5. Magainin Pharmaceuticals. $45,000. 1994-1996. "A Study of Comparative

Efficacy of MSI-78-303 Topical Cream vs Oral Ofloxacin in the Treatment of Infected Diabetic Foot Ulcers." Consultant.

6. University of Colorado [Department of Surgery]. $65,000. 1994-97. "The

Effect of Recombinant Human tPA Expression by Transduced Seeded Endothelial Cells on Neointimal Hyperplasia after Arterial Endarterectomy or Intra-arterial Balloon Injury." Principal Investigator.

7. ETI (EVT) Endograft Clinical Trial. $104,407. 1994-1998. “Trial of a New

Endovascular Repair Device for Abdominal Aortic Aneurysms.” Sub-Investigator.

8. Rhone-Poulec Rorer Pharmaceuticals, Inc. $104,498. 1994-1998. “A

multicenter, randomized, partially-blind, parallel group clinical trial to compare the efficacy and safety of twice and once daily subcutaneously administered Enoxaparin and continuous infusion heparin in the treatment

5


of patients with deep vein thrombosis with or without pulmonary embolism.” Co-Investigator.

9. Sigma-tau Pharmaceuticals, Inc. $79,000. 1994-1996. “Randomized clinical

evaluation of propionyl-L-carnitine for treatment of patients with claudication.” Co-Investigator.

10. Colorado State University [College of Veterinary Medicine and Biomedical

Sciences]. $32,000, 1995-97. "The Effect of Ovariectomy on Cardiovascular Function and Vascular Remodeling in Sheep." Co-Principal Investigator.

11. Schwarz Pharma Kremers Urban Co. $126,375. 1995-1997. "A Double-Blind,

Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vasoprost in the Treatment of Patients with Severe Intermittent Claudication Due to Peripheral Arterial Occlusive Disease." Principal Investigator.

12. Abbott Laboratories Venous Registry. $7,500. 1996-1998. “A Multicenter,

Cooperative Effort Collecting Data on Catheter-Directed Thrombolysis of Iliofemoral Deep Venous Thrombosis.” Sub-Investigator.

13. National Institutes of Health [National Institute of Aging] RO3 PA-96-023.

$72,460. 1997-1998. "The Aged Ovariectomized Ewe as a Model of Menopause." Co-Principal Investigator.

14. Pacific Vascular Research Foundation. $49,841. 1998-1999. “Interleukin-10

and Vascular Stenosis.” Principal Investigator.

15. John A. Hartford Foundation/Jahnigen Center of Excellence Mid-career Fellowship/Stipend Award. $55,000. 1998-1999. “The Importance of Co-Existent Disease in the Occurrence of Post-operative Complications and One-Year Functional Outcome in Geriatric Patients Undergoing Elective Aortic Aneurysm Surgery: Comorbidity and Outcomes after Aortic Surgery.” Principal Investigator.

16. American Geriatrics Society/John A. Hartford Foundation Education Project.

$6,000. 1998-2000. “Increasing Geriatrics Expertise in Non-Primary Care Specialties.” Principal Investigator.

17. University Hospital/University of Colorado. $4,000. 1998-1999. Clinical

Value Award - “An Evidenced-Based Practice Guideline for Use of Sequential Compression Devices and Elastic Stockings as a Prophylactic Intervention for Prevention of Deep Venous Thrombosis.” Co-Principal Investigator.

18. VA Cooperative Studies Center, Hines, IL. $1,300,000. 1998-2006.

6


“CSP #411 - The Coronary Artery Revascularization Prophylaxis (CARP) Trial.” Co-Investigator.

19. EPIX Medical/Mallinckrodt, Inc. 1999-2002. “A Multicenter, Comparative,

Two Arm, Phase 3 Study to Determine the Safety and Efficacy of AngioMARK-Enhanced MRA for Evaluation of Aortoiliac Occlusive Disease in Patients with Known or Suspected Peripheral Vascular Disease or Aortic Aneurysm.” Co-Investigator.

20. VA Cooperative Studies, Hines, IL. 2006- 2008. "Benefits of 'repeat back' within a computer-based informed consent program (ORBIT study)". Sub-investigator.

BIBLIOGRAPHY REFERENCED JOURNAL PUBLICATIONS

1. Whitehill TA, Pearce WH, VanWay CW, Rosales C, Go VLW, Rutherford RB: Elevation in serum vasoactive intestinal polypeptide (VIP) following ligation of the superior mesenteric artery. Surgical Forum XXXVII: 439-41, 1986.

2. Pearce WH, Whitehill TA, Rutherford RB, Rosales C, Ramalanjaona G, Patt

A: Successful endothelial seeding using omentally-derived microvascular endothelial cells. J Vasc Surg 5:302-06, 1987.

3. Pearce WH, Jones DN, Warren G, Bartle EJ, Whitehill TA, Rutherford RB:

A comparative study of the use of fluorescein, Doppler ultrasound and photoplethysmography in identifying early intestinal ischemia. Arch Surg 122:308-10, 1987.

4. Whitehill TA, Pearce WH, Rosales C, Van Way CW, Yano T, Rutherford RB:

Detection thresholds of non-occlusive intestinal hypoperfusion by Doppler ultrasound, photoplethysmography, and fluorescein. J Vasc Surg 8:28-32, 1988.

5. Pearce WH, Rutherford RB, Whitehill TA, Davis K: Nuclear magnetic

resonance imaging: Its diagnostic value in patients with congenital vascular malformations of the limbs. J Vasc Surg 8:64-70, 1988.

6. Piotrowski JJ, Pearce WH, Jones DN, Whitehill TA, Bell RCW, Patt A,

Rutherford RB: Aortobifemoral bypass: The operation of choice for unilateral iliac occlusion? J Vasc Surg 8:211-18, 1988.

7


7. Pearce WH, Whitehill TA: Carotid and Vertebral Arterial Injuries. Surg Clin North Am 68(4):705-23, 1988.

8. Whitehill TA, Rutherford RB: Acute intestinal ischemia caused by arterial

occlusions Optimal management to improve survival. Seminars in Vascular Surgery 3:149-56, 1990.

9. Whitehill TA, Moore FA: Upper extremity vascular injury. Seminars in

Vascular Surgery 3:250-57, 1990.

10. Jones DN, Rutherford RB, Ikezawa T, Nishikimi N, Ishibashi H, Whitehill TA: Factors affecting the patency of small caliber prostheses: Observations in a suitable canine model. J Vasc Surg 14:441-51, 1991.

11. Mansour MA, Moore EE, Moore FA, Whitehill TA: Conservative

management of penetrating neck wounds - a 12-year prospective analysis. Am J Surg 162:517-21, 1991.

12. Podrazik RM, Whitehill TA, Ekhterae D, Williams WD, Messina

LM, Stanley JC: High level expression of recombinant human tPA in cultivated canine endothelial cells under varying conditions of retroviral gene transfer. Ann Surg 216:446-53, 1992.

13. Whitehill TA, Podrazik RM, Ekhterae D, Messina LM, Stanley JC:

Retroviral-mediated human tPA gene transfer in canine endothelial cells: Comparative effects of protamine and polybrene on cellular transduction and gene expression. Surgical Forum XLIII:337-40, 1992.

14. Messina LM, Podrazik RM, Whitehill TA, Ekhterae D, Brothers TE, Wilson

JM, Burkel WE, Stanley JC: Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci USA 89:12018-022, 1992.

15. Moore FA, Haenel JB, Moore EE, Whitehill TA: Incommensurate oxygen

consumption in response to maximal oxygen availability predicts postinjury multiple organ failure. J Trauma 33:58-65, 1992.

16. Podrazik RM, Whitehill TA, Komorowski TA, Karo KH, Messina LM,

Stanley JC: In vivo fate of lacZ-transduced endothelial cells seeded on ePTFE thoracoabdominal vascular prostheses in dogs. Surgical Forum XLIV:402-06, 1993.

17. Messina LM, Ekhterae D, Whitehill TA, Podrazik RM, Burkel WE, Ford J,

Gardner AK, Stanley JC: Transplantation of lacZ-transduced microvascular endothelial cells into skeletal muscle capillary bed of the rat hindlimb occurs

8


independent of the duration of femoral artery occlusion after injection of cells. J Surg Res 57:661-66, 1994.

18. Whitehill TA: Caval interruption methods: Comparison of options.

Seminars in Vascular Surgery 9:59-69, 1996.

19. Erdoes L, Marek JE, Berman SA, Whitehill TA, Mills JL, Krupski WC, Hunter GC: The relative contributions of duplex scanning, magnetic resonance angiography and arteriography to clinical decision making: A prospective study in patients with carotid occlusive disease. J Vasc Surg 23:950-56, 1996.

20. Baer RP, Whitehill TA, Sarkar R, Sarkar M, Messina LM, Komorowski TA,

Stanley JC: Retroviral-mediated transduction of endothelial cells with the lacZ gene impairs cellular proliferation in vitro and graft endothelialization in vivo. J Vasc Surg 24:892-99, 1996.

21. Whitehill TA: Role of revascularization in the treatment of claudication.

Vascular Medicine 2:252-56, 1997.

22. Krupski WC, Selzman CH, Whitehill TA: Unusual etiologies of mesenteric ischemia. Surg Clin North Am 77(2):471-502, 1997.

23. Selzman CH, Turner AS, Johnson SM, Cain BS, Harken AH, Whitehill TA:

Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids, J Card Surg 12:228-34, 1997.

24. Subber S, Russ PD, Whitehill TA, Krysl J: Diagnosis and localization of a

spontaneous aortocaval fistula by computed tomography wth angiographic confirmation. Can Assoc Radiologists Journal 49:35-38, 1998.

25. Selzman CH, Whitehill TA, Shames BD, Pulido EJ, Cain BC, Harken AH:

The biology of estrogen-mediated repair of cardiovascular injury, Annals of Thoracic Surgery 65:868-74, 1998.

26. Krupski WC, Selzman CH, Florida R, Strecker PK, Nehler MR, Whitehill

TA: Contemporary management of isolated iliac aneurysms. J Vasc Surg 28:1-13, 1998.

27. Whitehill TA, Miller SA, Turner AS, Gaynor JS, Harken AH, Selzman CH:

Ovarian ablation alone induces atherosclerosis and the accumulation of fibroblast growth factor which are inhibited with estrogen replacement. Surgical Forum XLIX:316-18, 1998.

9


28. Selzman CH, Shames BD, Whitehill TA, Harken AH, McIntyre RC: Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation. Surgery 124:318-27, 1998.

29. Selzman CH, Whitehill TA, Krupski WC: Thrombophilia and activated

protein C resistance. Annals of Vascular Surgery 12:601-04, 1998.

30. Selzman CH, McIntyre RC, Shames BD, Whitehill TA, Banerjee A, Harken AH: Interleukin-10 inhibits human vascular smooth muscle proliferation. J Mol Cell Cardiol 30:889-96, 1998.

31. Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz LD, Whitehill

TA, Harken AH: Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation 98:2049-54, 1998.

32. Selzman CH, Gaynor JS, Turner AS, Whitehill TA, Horwitz LD, Harken

AH: Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor-beta1. J Surg Res 80:380-85, 1998.

33. Nehler MR, Whitehill TA, Bowers SP, Jones, DN, Rutherford RB, Hiatt WH,

Krupski WC: Intermediate term natural history of primary digit amputations in diabetic patients with forefoot sepsis and adequate circulatory status. J Vasc Surg 30:509-18, 1999.

34. Selzman CH, Miller SA, Gaynor JS, Whitehill TA, Harken AH, Turner AS:

The selective estrogen receptor modulator, raloxifene, inhibits aortic intimal hyperplasia in the ovariectomized ewe. Surgical Forum XLX:464-65, 1999.

35. Krupski WC, Nehler MR, Whitehill TA, Lawson RC, Strecker PK, Hiatt WR:

Negative impact of cardiac evaluation before vascular surgery. Vasc Med 5:3-9, 2000.

36. Miller SA, Selzman CH, Pulido EJ, Zimmerman MA, Whitehill TA, Harken

AH: Interleukin-10 Attenuates the Arterial Inflammatory Response to Injury. Surgical Forum XLXI:390-91, 2000.

37. Whitehill TA: Current Vena Caval Filter Devices and Results. Seminars in

Vascular Surgery 13:204-12, 2000.

38. Gaynor JS, Monnet E, Selzman CH, Parker D, Kaufman L, Bryant HU, Knadler MP, Mallinckrodt C, Wrigley R, Whitehill TA, Turner AS: The effect of raloxifene on coronary angiography in aged ovariectomized ewes. J Vet Pharmacol Therapeutics 23:175-9, 2000.

10


39. Nehler MR, Lawrence WA, Whitehill TA, Charette SD, Jones DN, Krupski WC: Iatrogenic vascular injuries from percutaneous vascular suturing devices. J Vasc Surg 33:943-7, 2001.

40. Charette S, Nehler MR, Whitehill TA, Gibbs P, Foulk D, Krupski WC:

Epitheliod hemangioendothelioma of the common femoral vein: Case report and review of the literature. J Vasc Surg 33:1100-3, 2001.

41. Krupski WC, Nguyen HT, Jones DN, Wallace H, Nehler MR, Whitehill TA:

Smoking Cessation: A missed opportunity. J Vasc Surg 36:257-62, 2002.

42. Krupski WC, Nehler MR, Whitehill TA: Preoperative Cardiac Risk Management. Cardiovasc Surgery 10:415-20, 2002.

43. Nehler MR, Mueller RJ, McLafferty RB, Johnson S, Nussbaum JD, Mattos

MA, Whitehill TA, Ramsey DE, Esler A, Hodgsen KJ, Krupski WC: Outcome of Catheter-Directed Thrombolysis for Lower Extremity Arterial Bypass Occlusion. J Vasc Surg 37:72-8, 2003.

44. Nehler MR, Coll JR, Hiatt WR, Regensteiner JG, Schnickel G, Klenke WA,

Strecker PK, Anderson MW, Jones DN, Whitehill TA, Krupski WC: The Functional Outcome in a Contemporary Series of Major Lower Extremity Amputations. J Vasc Surg 38:7-14, 2003.

45. Nehler MR, Salter KD, Esler AL, Hiatt WR, Regensteiner JG, Strecker PK,

Anerson MW, Klenke WA, Jones DN, Whitehill TA, Krupski WC: Morbidity and Function Following Infrainguinal Bypass for Critical Limb Ischemia. J Vasc Surg (submitted).

ABSTRACTS / POSTERS

1. Friese R, Whitehill TA. Neointimal thickening in arteriovenous loop PTFE grafts is promoted by increased graft porosity. Society of University Surgeons, Jackson, Mississippi, February 12, 1994. [presentation]

2. Rowland RT, Whitehill TA, Rehring TF, Krupski WC, Rutherford RB. The

value of arch angiography in the diagnosis of chronic or recurrent upper extremity arterial occlusions. American College of Surgeons [Colorado Chapter], Breckenridge, Colorado, June 8, 1995. [presentation]

3. Erdoes L, Marek JE, Berman SA, Whitehill TA, Mills JL, Krupski WC,

Hunter GC: The relative contributions of duplex scanning, magnetic resonance angiography and arteriography to clinical decision making: A prospective study in patients with carotid occlusive disease. SVS/ISCVS, New Orleans, Louisiana, June 14, 1995. [presentation]

11


4. Krupski WC, Whitehill TA, Lawson RC, Strecker PK, Rutherford RB:

Cleared by cardiology: The downside of routine preoperative cardiac evaluation before vascular surgery. Western Vascular Society, Laguna Nigel, California, January 24, 1996. [presentation]

5. Selzman CH, Whitehill TA. Estrogen replacement inhibits the development

of intimal hyperplasia independent of serum lipids. Society of University Surgeons Resident's Forum, Tampa, Florida, February 15, 1997. [presentation]

6. Russ PD, Garg K, Weingardt JP, Durham J, Whitehill TA: MRI of

peripheral (extra-CNS) vascular malformations. American Roentgen Ray Society, Boston, Massachusetts, May 6, 1997, [poster]

7. Selzman CH, Whitehill TA. Chronic estrogen replacement inhibits aortic

intimal hyperplasia. American College of Surgeons [Colorado Chapter], Keystone, Colorado, June 12, 1997. [First place winner - Best Resident Basic Science Presentation/Paper.]

8. Krupski WC, Selzman CH, Florida R, Whitehill TA. Contemporary

management of isolated iliac aneurysms. Western Vascular Society, Lana'i, Hawaii, September 30, 1997. [presentation]

9. Selzman CH, McIntyre RC, Shames BD, Pulido EJ, Whitehill TA, Harken

AH: Class II cytokine ligands inhibit human vascular smooth muscle proliferation. Society of University Surgeons, Milwaukee, Wisconsin, February 13, 1998. [presentation]

10. Selzman CH, Whitehill TA. Estradiol inhibits vascular smooth muscle

proliferation via nitric oxide. J Mol Cell Cardiol, Meeting Abstract 214, 1998. [presentation]

11. Selzman CH, Whitehill TA, Harken AH. Interleukin-10 inhibits human

vascular smooth muscle proliferation. FASEB, San Francisco, California, March 18, 1998. [poster]

12. Nehler MR, Whitehill TA, Bowers SP, Jones, DN, Rutherford RB, Hiatt WH,

Krupski WC. Intermediate term natural history of primary digit amputations in diabetic patients with forefoot sepsis and adequate circulatory status. Western Vascular Society, Whistler, British Columbia, September 14, 1998. [presentation]

12


13. Whitehill TA, Donohue RE. Prevention of deep venous thrombosis and thromboembolism. South Central Section of the American Urologic Association, Santa Fe, New Mexico, September 25-28, 1999. [presentation]

14. Krupski WC, Nehler MR, Whitehill TA, Hiatt WH. Enoxaparin versus

heparin in the treatment of patients with acute deep vein thrombosis: A cost analysis of patients treated in the United States. The American Society of Hematology, New Orleans, Louisiana, December 3, 1999. [poster/presentation]

15. Miller SA, Selzman CH, Zimmerman MA, Pulido EJ, Harken AH, Whitehill

TA. Interleukin-10 (IL-10) Inhibits the Inflammatory Response to Arterial Injury. The Society of university Surgeons resident's Program, Toronto, Ontario, February 10, 2000. [presentation]

16. Krupski WC, Nehler MR, Whitehill TA. Preoperative Cardiac Risk

Assessment. Naffziger Surgical Society, San Francisco, California, April 15, 2000. [presentation]

17. Nehler MR, Salter KD, Esler AL, Hiatt WR, Regensteiner JG, Strecker PK,

Jones DN, Whitehill TA, Krupski WC. Morbidity and Function Following Infrainguinal Bypass for Critical Limb Ischemia. American Association for Vascular Surgery, Toronto, Ontario, June 8, 2003. [presentation]

BOOK CHAPTERS

1. Density-Gradient Electrophoresis of Cells in a Vertical Column. Boltz RC, Whitehill TA, Todd PW: In Electrokinetic Separation Methods, Righetti PG, van Oss CJ, Vanderhoff JW, (eds.), Elsevier/North Holland, Amsterdam, 1979, 229-50.

2. Separation of Functioning Mammalian Cells by Density-Gradient

Electrophoresis. Todd PW, Whitehill TA, Boltz RC. In Electrophoresis '81, Allen CG, Arnaud TM, (eds.), Walter de

Gruyter & Company, Berlin, 1981, 871-82.

3. All Post-Operative Vascular Surgery Patients Should Receive Aspirin. Whitehill TA: In Surgical Debates I, Harken AH (ed.), Hanley & Belfus, Inc., Philadelphia, 1988, 101-13.

4. The Clinical Application of Endothelial Cell Tissue Culture.

Whitehill TA, Pearce WH: In In Vitro Models for Cancer Research, Webber MM, Sekely LL, (eds.), CRC Press, Boca Raton, 1988, 155-66.

13


5. Intermittent Mandatory Ventilation for Ventilatory Weaning. Whitehill TA: In Surgical Debates II, Harken AH, (ed.), Hanley & Belfus, Inc., Philadephia, 1989, 81-86.

6. Blunt Abdominal Trauma. Whitehill TA, Moore EE, Marx JA:

In The Clinical Practice of Emergency Medicine, Harwood-Nuss AL, Linden CG, Luten RC, Sternbach G, Wolfson AB, (eds.), J.B. Lippincott Company, Philadelphia, 1991, 363-64.

7. Penetrating Abdominal Trauma. Whitehill TA, Moore EE, Marx JA: In The

Clinical Practice of Emergency Medicine, Harwood-Nuss AL, Linden CG, Luten RC, Sternbach G, Wolfson AB, (eds.), J.B. Lippincott Company, Philadelphia, 1991, 364-67.

8. Arterial Pressure Monitoring and Central Venous Pressure Monitoring. Whitehill TA, Whitman GJR: In Surgical Secrets, Abernathy CM, Harken AH, (eds.), Hanley & Belfus, Inc., Philadelphia, 1991, 35-39.

9. Pulmonary Artery Pressure Monitoring. Whitman GJR, Whitehill TA: In

Surgical Secrets, Abernathy CM, Harken AH, (eds.), Hanley & Belfus, Inc., Philadelphia, 1991, 39-43.

10. Arterial Emboli. Whitehill TA: In Critical Care Secrets, Parsons PE,

Wiener-Kronish JP, (eds.), Hanley & Belfus, Inc., Philadelphia, 1991, 334-38.

11. Upper Extremity Deep Venous Thrombosis. Whitehill TA: In Critical Care Secrets, Parsons PE, Wiener-Kronish JP, (eds.), Hanley & Belfus, Inc., Philadelphia, 1991, 338-41.

12. New Developments in Caval Interruption: Current Indications and New

Techniques for Filter Placement. Greenfield LJ, Whitehill TA: In Current Critical Problems in Vascular Surgery, Veith FJ, (ed.), Quality Medical Publishing, Inc., St. Louis, 1992, 113-21.

13. Genetic Manipulation of Endothelium and Vascular Smooth Muscle.

Whitehill TA, Messina LM, Stanley JC: In Implantation Biology. The Host Response and Biomedical Devices, Greco RS, (ed.), CRC Press, Boca Raton, 1994, 315-28.

14. Carotid Artery Kinks and Coils. Whitehill TA: In Review of Vascular

Surgery, Krupski WC (ed.), W. B. Saunders, Philadelphia, 1994.

15. Colon Ischemia. Whitehill TA: In Review of Vascular Surgery, Krupski WC (ed.), W. B. Saunders, Philadelphia, 1994.

14


16. Vascular Complication of Ehlers-Danlos Syndrome and Marfan's Syndrome. Whitehill TA: In Current Therapy in Vascular Surgery, Ernst CB, Stanley JC (eds.), Mosby-Year Book, Philadelphia, 1995, 302-5.

17. Arterial Pressure Monitoring and Central Venous Pressure Monitoring.

Whitehill TA, Whitman GJR: In Surgical Secrets, Harken AH, (ed.), Hanley & Belfus, Inc., Philadelphia, 1996, 32-36.

18. Pulmonary Artery Pressure Monitoring. Whitman GJR, Whitehill TA: In

Surgical Secrets, Harken AH, (ed.), Hanley & Belfus, Inc., Philadelphia, 1996, 36-40.

19. Surgical Hypertension. Whitehill TA: In Surgical Secrets, Harken AH, (ed.),

Hanley & Belfus, Inc., Philadelphia, 1996, 181-85.

20. Venous Disease. Whitehill TA, Rutherford RB: In Surgical Secrets, Harken AH, (ed.), Hanley & Belfus, Inc., Philadelphia, 1996, 237-41.

21. Vena Caval Interruption and Filters. Greenfield LJ, Whitehill TA: In

Surgical Management of Venous Disease, Raju S, Villavicencio L, (eds.), Williams & Wilkins, Baltimore, 1997, 497-511.

22. Arterial Emboli. Whitehill TA: In Critical Care Secrets, Parsons PE,

Wiener-Kronish JP, (eds.), Hanley & Belfus, Inc., Philadelphia, 1998, 385-389.

23. Upper Extremity Deep Venous Thrombosis. Whitehill TA: In Critical Care

Secrets, Parsons PE, Wiener-Kronish JP, (eds.), Hanley & Belfus, Inc., Philadelphia, 1998, 389-392.

24. Uncommon Disorders Affecting the Carotid Arteries, Whitehill TA, Krupski

WC: In Vascular Surgery, Rutherford RB, (ed.), W.B. Saunders, Philadelphia, 1999, 1853-1881.

25. Lower Extremity Claudication. Whitehill TA: In Surgical Decision Making

IV, Norton LW, Stiegmann GV, Eiseman B, (eds.), W.B. Saunders, Philadelphia, 2000, 236-238.

26. Central Venous (CVP) and Pulmonary Artery Pressure (PAP) Monitoring.

Whitehill TA, Whitman GJR, Harken AH: In Surgical Secrets, Harken AH, Moore EE, (eds.), Hanley & Belfus, Inc., Philadelphia, 2000, 39-43.

27. Surgical Hypertension. Whitehill TA: In Surgical Secrets, Harken AH,

Moore EE, (eds.), Hanley & Belfus, Inc., Philadelphia, 2000, 194-196.

15


28. Venous Disease. Whitehill TA, Nehler MR: In Surgical Secrets, Harken AH, Moore EE, (ed.), Hanley & Belfus, Inc., Philadelphia, 2000, 243-246.

29. Management of Coexistent Splanchnic and Renal Artery Occlusive Disease

During Aortic reconstruction, Nehler MR, Whitehill TA, Krupski WC: In Current Therapy in Vascular Surgery, Ernst CB, Stanley JC, (eds.), Mosby-Year Book, Philadelphia, 2001, 252-257.

30. Surgical Hypertension. Whitehill TA: In Surgical Secrets, Harken AH,

Moore EE, (eds.), Hanley & Belfus, Inc., Philadelphia, 2003, 194-196.

31. Venous Disease. Whitehill TA, Nehler MR: In Surgical Secrets, Harken AH, Moore EE, (ed.), Hanley & Belfus, Inc., Philadelphia, 2003, 243-246.

32. Lower Extremity Claudication. Whitehill TA: In Surgical Decision Making

V, McIntyre RC, Stiegmann GV, Eiseman B, (eds.), W.B. Saunders, Philadelphia, 2004, 330-34.

33. Deep Vein Thrombosis. Whitehill TA: In Surgical Decision Making V,

McIntyre RC, Stiegmann GV, Eiseman B, (eds.), W.B. Saunders, Philadelphia, 2004, 354-58.

34. TOS chapter

INVITED PRESENTATIONS Scientific

1. Increased Serum Vasoactive Polypeptide Levels After Ligation of the Superior Mesenteric Artery. American College of Surgeons (Surgical Forum), New Orleans, Louisiana, October 20, 1986.

2. Nuclear Magnetic Resonance Imaging: Its Diagnostic Value in Patients with

Congenital Vascular Malformations of the Limbs. Peripheral Vascular Surgery Society, Toronto, Ontario, June 7, 1987.

3. Detection Thresholds of Non-Occlusive Intestinal Hypoperfusion by Doppler

Ultrasound, Photoplethysmography and Fluorescein. Society for Vascular Surgery, Toronto, Ontario, June 10, 1987.

4. Crossed Immunoelectrophoresis and Serum Protein Alterations due to

Ischemic Gut. Society of University Surgeons, San Antonio, Texas, February 10, 1988.

16


5. Intraarterial Urokinase in Extremity Vascular Trauma. Western Trauma Association, Jackson Hole, Wyoming, March 1, 1991.

6. Retroviral-mediated human tPA gene transfer in canine endothelial cells:

Comparative effects of protamine and polybrene on cellular transduction and gene expression. American College of Surgeons (Surgical Forum), New Orleans, Louisiana, October 12, 1992.

7. Ovarian ablation alone induces atherosclerosis and the accumulation of

fibroblast growth factor which are inhibited with estrogen replacement. American College of Surgeons (Surgical Forum), Orlando, Florida, October 28, 1998.

Invited/Educational

1. Routine Intraoperative Cholangiography. Surgical Grand Rounds, University of Colorado, August 24, 1984.

2. Lung Cancer with Mediastinal Metastases is not Inoperable. Surgical Grand

Rounds, University of Colorado, March 23, 1985.

3. Hepatic Metastases Should be Resected. Surgical Grand Rounds, University of Colorado, September 14, 1985.

4. Bleeding Esophageal Varices Should be Treated by Operation. Surgical

Grand Rounds, University of Colorado, February 8, 1986.

5. Bleeding Esophageal Varices Should be Treated by Operation. Horizons in Surgery, Breckenridge, Colorado, March 21, 1986.

6. Blunt Abdominal Trauma is Best Diagnosed by Peritoneal lavage. Surgical

Grand Rounds, University of Colorado, July 12, 1986.

7. Aspirin and the Post-Operative Vascular Surgery Patient. Surgical Grand Rounds, University of Colorado, September 6, 1986.

8. Drug Therapy for Peripheral Vascular Embolic Occlusion. Surgical Grand

Rounds, University of Colorado, January 31, 1987.

9. Aspirin and the Post-Operative Vascular Surgery Patient. Horizons in Surgery, Winter Park, Colorado, March 1, 1987.

10. Intermittent Mandatory Ventilation. Surgical Grand Rounds, University of

Colorado, July 11, 1987.

17


11. Percutaneous Transluminal Angioplasty for Peripheral Vascular Disease. Horizons in Surgery, Winter Park, Colorado, February 25, 1988.

12. Autotransfusion in Major Trauma. Surgical Grand Rounds, University of

Colorado, March 19, 1988.

13. Exercise Increases Longevity. Surgical Grand Rounds, University of Colorado, January 7, 1989.

14. Exercise and its Effects on Longevity, Horizons in Surgery, Winter Park,


15. Primary Amputation Versus Reconstruction for Ischemic Vascular Disease. Surgical Grand Rounds, University of Colorado, September 9, 1989.

16. Primary Amputation for Ischemic Vascular Disease, Horizons in Surgery,

Breckenridge, Colorado, March 6, 1990.

17. Mechanical Ventilation in the SICU. Surgical Grand Rounds, University of Colorado, August 18, 1990.

18. Hypoxic Events in the SICU, Horizons in Surgery, Breckenridge, Colorado,

March 4, 1991.

19. Traumatic Ischemia: Management Strategies, Rocky Mountain Vascular Disease Symposium, Steamboat Springs, Colorado, March 28, 1991.

20. Traumatic Ischemia of the Extremities. Emergency Medicine Grand Rounds,

Denver General Hospital, June 6, 1991.

21. Carotid Arterial Surgery: State of the Art. Surgical Grand Rounds, University of Michigan, March 20, 1993.

22. Aortic and Peripheral Arterial Aneurysmal Disease. Surgical Grand Rounds,

University of Colorado, December 4, 1993.

23. Present Management of Renovascular Hypertension. Northern Plains Vascular Surgical Society, Denver, Colorado, January 8, 1994.

24. Aortic Aneurysm 1994, Horizons in Surgery, Breckenridge, Colorado, March

4, 1994.

25. Carotid Artery Disease - To Operate or Not. Surgical Grand Rounds, University of Colorado, September 17, 1994.

18


26. Care of the Diabetic Foot. Northern Plains Vascular Surgical Society, Denver, Colorado, January 7, 1995.

27. Care of the Diabetic Foot in 1995. Horizons in Surgery, Breckenridge,


28. Peripheral Vascular Disease and Women, Rocky Mountain Vascular Disease Symposium, Beaver Creek, Colorado, March 15, 1995.

29. Vascular Surgery Outcomes Assessment: Critical Clinical Pathways, Rocky

Mountain Vascular Disease Symposium, Beaver Creek, Colorado, March 17, 1995.

30. Peripheral Vascular Disease and Women, Center for Vascular Diseases

Grand Rounds, University of Colorado, Denver, Colorado, April 5, 1995.

31. Peripheral Vascular Disease and Women, Secretarial Grand Rounds [Surgery], University of Colorado, Denver, Colorado, May 8, 1995.

32. Atherosclerosis and the Pathogenesis of Occlusive Disease, Surgical Grand

Rounds, University of Colorado, October 7, 1995.

33. Carotid Artery Disease, Cardiology Grand Rounds, University of Colorado, October 18, 1995.

34. Atherosclerosis and the Pathogenesis of Occlusive Disease, Northern Plains

Vascular Surgery Society, Denver, Colorado, January 13, 1996.

35. The Surgical Management of Renal Artery Occlusive Disease. Rocky Mountain Vascular Disease Symposium, Keystone, Colorado, March 14, 1996.

36. Operating in the Face of Limb-Threatening Ischemia. Rocky Mountain

Vascular Disease Symposium, Keystone, Colorado, March 14, 1996.

37. Vascular Complications of Pelvic Surgery. Surgical Grand Rounds, University of Colorado, March 23, 1996.

38. Acute Peripheral Arterial Occlusions. A Review of Arterial and Venous

Thrombosis, Hyatt Regency Tech Center, Denver, Colorado, April 5, 1996.

39. Peripheral Vascular Disease and Women. The Islands Vascular Disease Symposium, Key Biscayne, Florida, April 14, 1996.

40. Vascular Surgery Outcomes Assessment: Critical Clinical Pathways. The

Islands Vascular Disease Symposium, Key Biscayne, Florida, April 15, 1996.

19


41. Indications for Carotid Endarterectomy: The Impact of Consensus

Statements and Randomized Trials. The Islands Vascular Disease Symposium, Key Biscayne, Florida, April 17, 1996.

42. The Diabetic Foot. Surgical Grand Rounds, University of Colorado,

May 4, 1996.

43. The Use of Low-Molecular Weight Heparin in the Prophylaxis of Deep Venous Thrombosis and Pulmonary Embolism. Surgical Grand Rounds, St. Anthony's Hospital System, Denver, Colorado, May 6, 1996.

44. Diagnostic Management of DVT and Pulmonary Embolism. Citywide Grand

Rounds, Gaston Memorial Hospital, Gastonia, North Carolina, September 3, 1996.

45. The Atheroprotective Effects of Estrogens. Frederick Coller Surgical Society,

The Broadmoor Hotel, Colorado Springs, Colorado, October 4, 1996.

46. Best Management Practices in the Care of the Patient with Claudication. Grand Rounds, Cheyenne VA Medical Center, Cheyenne, Wyoming, October 22, 1996.

47. Vascular Gene Therapy. American College of Veterinary Surgeons, San

Francisco, California, November 4, 1996. 48. Role of Revascularization for Claudication. A Medical Approach to the

Management of Patients with Claudication. American Heart Association, New Orleans, Louisiana, November 10, 1996.

49. Clinical Pathways as a Means of Eliminating Unnecessary Cost in Vascular

Surgery. Rocky Mountain Vascular Disease Symposium, Snowmass, Colorado, March 20, 1997.

50. The "Fast Track" Carotid Endarterectomy: Selection Guidelines. Rocky

Mountain Vascular Disease Symposium, Snowmass, Colorado, March 20, 1997.

51. Endovascular Treatment of Abdominal Aortic Aneurysms. University

Hospital Grand Rounds, Denver, Colorado, October 28, 1997.

52. Balloons, Stents, Endografts, and Other Vascular Wizardry, Surgical Grand Rounds, University of Colorado, Denver, Colorado, November 22, 1997.

20


53. Vascular Surgery Anastomotic and Grafting Techniques, Surgical/Clinical Training Course, Colorado State University School of Veterinary Medicine, Ft. Collins, Colorado, December 1-2, 1997.

54. Balloons, Stents, Endografts, and Other Vascular Wizardry, Northern Plains

Vascular Surgical Society, Denver, Colorado, January 17, 1998.

55. What's New in Vascular Surgery, Hospital Grand Rounds, Steamboat Springs Hospital, Steamboat Springs, Colorado, February 5, 1998.

56. What's New in Vascular Surgery, Grand Rounds, Craig General Hospital,

Craig, Colorado, February 6, 1998.

57. Cost Effective Care of Vascular Disease, Horizons in Surgery, Breckenridge, Colorado, March 13, 1998.

58. The Fast Track Carotid Endarterectomy: Selection Guidelines, Rocky

Mountain Vascular Disease Symposium, Vail, Colorado, March 17, 1998.

59. Graft Choices for Infrainguinal Bypass, Rocky Mountain Vascular Disease Symposium, Vail, Colorado, March 20, 1998.

60. Update on Endovascular Aortic Surgery. Aspen Valley Hospital Grand

Rounds, Aspen, Colorado, July 14, 1998.

61. Lipoprotein a [Lp(a)] and Premature Atherosclerosis. Rocky Mountain Vascular Surgery Society, Vail, Colorado, August 14, 1998.

62. Surgery for Renovascular Hypertension. Rocky Mountain Vascular Surgery

Society, Vail, Colorado, August 14, 1998.

63. Cost Effective Care of Vascular Disease. Surgical Grand Rounds, University of Colorado, Denver, Colorado, September 19, 1998.

64. Surgery for Carotid Disease. The 3rd Annual Vascular Intervention

Conference, Lancaster General Hospital, Lancaster, Pennsylvania, November 14, 1998.

65. The Future of Therapy for AAA. The 3rd Annual Vascular Intervention

Conference, Lancaster General Hospital, Lancaster, Pennsylvania, November 14, 1998.

66. Medical Therapy for PVD. The 3rd Annual Vascular Intervention Conference,

Lancaster General Hospital, Lancaster, Pennsylvania, November 14, 1998.

21


67. Contemporary Treatment of Varicose Veins: Sclerotherapy versus Operative Treatment. Northern Plains Vascular Surgical Society, Denver, Colorado, January 16, 1999.

68. What’s New in DVT Management? Horizons in Surgery, Breckenridge,


69. A Rationale Approach to DVT Prophylaxis. Wisconsin Surgical Club, Denver, Colorado, April 30, 1999.

70. Outcomes of Vascular Surgery in Women. Society for Vascular Medicine and

Biology, Washington D.C., June 5, 1999.

71. Aneurysms. Surgical Grand Rounds, University of Colorado, Denver, Colorado, February 12, 2000.

72. Amputations: The Realities, Physical Medicine and Rehabilitation course on

Prosthetics and Orthotics, Denver, Colorado, April 6, 2000.

73. Contemporary Management of Abdominal Aortic Aneurysms, Surgical Grand Rounds, Exempla St. Joseph Hospital, Denver, Colorado, June 16, 2000.

74. Hematological Problems in General Surgery - Bleeding and Thrombosis,

Surgical Grand Rounds, Denver, Colorado, September 9, 2000.

75. Mesenteric Vascular Disease, Northern Plains Vascular Surgical Society, Denver, Colorado, January 13, 2001.

76. Prothrombotic States and Coagulation, Surgical Grand Rounds, Denver,

Colorado, September 8, 2001.

77. Integrated Vascular Centers, Northern Plains Vascular Surgical Society, Denver, Colorado, January 19, 2002.

78. Carotid Endarterectomy or Carotid Stenting? Horizons in Surgery,

Breckenridge, Colorado, March 8, 2002.

79. Clotting and Bleeding in General Surgery, Surgical Grand Rounds, Denver, Colorado, August 19, 2002.

80. Contemporary Management of Carotid Occlusive Disease, Northern Plains Vascular Surgical Society, Denver, Colorado, January 18, 2003.

81. Surveillance, Revision, and Outcomes of Surgical Access Procedures for

Hemodialysis, RMAVIR, Denver, Colorado, January 25, 2003.

22


82. Prevention of Deep Venous Thrombosis – Facts and Fiction, Surgical House

staff Association Meeting, March 4, 2003.

83. Current Status of Carotid Artery Stenting, Medical Staff Grand Rounds, Valley View Hospital, Glenwood Springs, Colorado, March 12, 2003.

84. Rationale for Prolonged Treatment of Deep Venous Thrombosis, Surgical

Grand Rounds, St. Mary’s Regional Hospital, Grand Junction, Colorado, March 13, 2003.

85. Surgical Treatment Options for Aortic Aneurysms and Dissections, Medical

Staff Grand Rounds, Memorial Hospital, Montrose, Colorado, March 14, 2003.

86. Hematological Problems in General Surgery: Abnormal Thrombosis, Surgical

Grand Rounds, University of New Mexico, Albuquerque, New Mexico, May 30, 2003.

87. Prevention of Venous Thromboembolism, Surgical Grand Rounds, Denver,

Colorado, April 14, 2003.

88. Care of the Vascular Patient, Advanced Medical/Surgical Nursing Concepts, UCHSC School of Nursing, Denver, Colorado July 30, 2003.

89. Hematological Problems in General Surgery: Abnormal Thrombosis, Surgical

Grand Rounds, Denver, Colorado, October 6, 2003.

90. New Anticoagulants, Northern Plains Vascular Surgical Society, Denver, Colorado, January 17, 2004.

91. What’s New in Vascular Surgery, Surgical Grand Rounds, Denver, Colorado,

September 13, 2004.

92. Vascular Practice Integration – Is it really working? Northern Plains Vascular Surgical Society, Denver, Colorado, January 15, 2005.

93. What’s New in Vascular Surgery, Horizons in Surgery, Breckenridge,

Colorado, March 2, 2005. 94. Credible Databases, Colorado Chapter, American College of Surgeons,

Denver, Colorado, July 8, 2005.

23


95. Local Experience with the VA National Surgical Quality Improve Project, Colorado Chapter, American College of Surgeons, Denver, Colorado, July 8, 2005.

96. Surgical Education in Colorado, Colorado Chapter, American College of

Surgeons, Denver, Colorado, July 8, 2005.

97. Coagulation for the Surgeon, Surgical Grand Rounds, Denver, Colorado, October 3, 2005.

98. Vena Cava Filters: Changing Perspectives, Northern Plains Vascular

Surgical Society, Denver, Colorado, January 14, 2006.

99. Perils and Pearls of Anticoagulation, Horizons in Surgery, Breckenridge, Colorado, March 15, 2006.

100. Coagulation and the Surgeon, Surgical Grand Rounds, Denver, Colorado,

November 6, 2006. INVITED MODERATOR / DISCUSSANT

1. Discussant: Thrombolysis versus Thrombectomy / Deep Venous Thrombosis Prophylaxis - Valuable versus Overrated. Horizons in Surgery, Breckenridge, Colorado, March 4, 1994.

2. Moderator: Thirty-Seventh Annual University Surgical Residents' Conference

[Vascular Surgery]. The Society of University Surgeons, Denver, Colorado, February 11, 1995.

3. Moderator: Diseases of the Visceral Branches of the Aorta. Rocky Mountain

Vascular Disease Symposium, Beaver Creek, Colorado, March 16, 1995.

4. Moderator: Assessing the Results of Vascular Interventions in the 1990s. Rocky Mountain Vascular Disease Symposium, Beaver Creek, Colorado, March 17, 1995.

5. Moderator: Venous Disease, Rocky Mountain Vascular Disease Symposium,

Keystone, Colorado, March 14, 1996.

6. Discussant: Endovascular Device versus Surgical Vascular Reconstruction. Horizons in Surgery, Breckenridge, Colorado, March 15, 1996.

7. Moderator: Diseases of the Visceral Branches of the Aorta. The Islands

Vascular Disease Symposium, Key Biscayne, Florida, April 18, 1996.

24


8. Discussant: Atherosclerosis, the Pathogenesis of Occlusive Disease, Neointimal Hyperplasia, and the Healing Response of Prosthetic Graft-Tissue Interfaces. W.L. Gore & Associates, Inc., Flagstaff, Arizona, April 26, 1996.

9. Reviewer: Validating Risk-Adjusted Surgical Outcomes: Chart Review of

Process of Care, Chicago, Illinois, October 16-18, 1996.

10. Discussant: Preoperative "Cardiac Clearance:" Valuable versus Useless. Horizons in Surgery, Breckenridge, Colorado, March 14, 1997.

11. Moderator: Lower Extremity Revascularization - Infrainguinal. Rocky

Mountain Vascular Disease Symposium, Snowmass, Colorado, March 19, 1997.

12. Moderator: Contemporary Utilization of Stented Grafts [Endografts] in

Clinical Vascular Surgery, Northern Plains Vascular Surgery Society, Denver, Colorado, January 17, 1998.

13. Moderator: Hemodialysis Angioaccess: Management Approaches, Rocky

Mountain Vascular Disease Symposium, Vail, Colorado, March 20, 1998. 14. Moderator: Scientific Session, Colorado Chapter of the American College of

Surgeons, Breckenridge, Colorado, June 10, 1999. 15. Discussant: Cardiac Work-up for Vascular Surgery Patients. Horizons in

Surgery, Breckenridge, Colorado, March 17, 2000.

16. Discussant: Endograft Therapy for Abdominal Aortic Aneurysm – a mixed blessing, Horizons in Surgery, Breckenridge, Colorado, March 8, 2002.

17. Moderator: Intermittent Claudication: Interventional vs. Medical

management, Northern Plains Vascular Surgical Society, Denver, Colorado January 18, 2003.

18. Discussant: Asymptomatic Carotid Stenosis – Operate versus Medicate,

Horizons in Surgery, Breckenridge, Colorado, March 7, 2003.

19. Moderator: Problematic Dialysis Access, Northern Plains Vascular Surgical Society, Denver, Colorado, January 17, 2004.

20. Moderator: Venous Reflux Disease, Northern Plains Vascular Surgical

Society, Denver, Colorado, January 15, 2005.

25


21. Moderator: Chronic Mesenteric Ischemia, Northern Plains Vascular Surgical Society, Denver, Colorado, January 14, 2006.

26


TEACHING ACTIVITIES University of Colorado School of Medicine Education, Direction, and Coordination Surgery 7000 Clinical Clerkship in Surgery 1993-1997 Lecturer 4 hrs/week 48 weeks/year 1997-present Course Director 8 hrs/week 48 weeks/year Surgery 8007 Surgical Anatomy 1997-2000 Course Director 8 hrs/week 2 weeks/year Curriculum Development and Instructional Design Surgery 7000 Clinical Clerkship in Surgery 1993-1997 Lecturer 4 hrs/week 48 weeks/year 1997-present Course Director 8 hrs/week 48 weeks/year Surgery 8000 General Surgery Subinternship at University Hospital 1997-present Course Director 4 hrs/week 16 weeks/year Surgery 8017 Special Senior Preceptorship 1997-present Course Director 2 hrs/week 8 weeks/year Course Administration Surgery 8000 General Surgery Subinternship at University Hospital Surgery 8017 Special Senior Preceptorship Surgery 8100 Course Work Away in Denver Surgery 8200 Course Work Away in Colorado Surgery 8300 Course Work Away Outside Colorado Surgery 8600 Research in Surgery Surgery 8630 Research in Surgery Outside Colorado Course Lecturer CSBI 5000 Human Anatomy IDPT 8001 Preparing For Residency PHSL 5000 Principles of Mammalian Physiology

27


28

Career Advisor/Mentor

1993-1994 8 students 2000-2001 12 students 1994-1995 10 students 2001-2002 9 students 1995-1996 10 students 2002-2003 18 students 1996-1997 16 students 2003-2004 23 students 1997-1998 19 students 2004-2005 8 students 1998-1999 20 students 2005-2006 12 students 1999-2000 18 students 2006-2007 14 students

University of Colorado Department of Surgery Surgical Residency 1993-present Daily Clinical rounds with residents and students 1993-present Weekly VS/IR combined arteriogram review 1994-present Weekly NIVL teaching rounds 1993-present Monthly Vascular Surgery curriculum lecture series 1993-1996 Monthly Colorado Vascular Surgery Society 1993-2003 Monthly Vascular Surgery Journal Club 1993-2003 Monthly General Surgery review – vascular topics 1993-2003 Yearly Abernathy review [“Parkland papers”]

Thomas A. Whitehill, M.D., F.A.C.S. · CV - T.A. Whitehill, M.D. 2002 - 2004 Member, Curriculum...

Documents

Transcript of Thomas A. Whitehill, M.D., F.A.C.S. · CV - T.A. Whitehill, M.D. 2002 - 2004 Member, Curriculum...